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ABSTRACT 
The objective of this study was to determine the optimum operating conditions 
for the effective treatment of a pharmaceutical wastewater by sequencing batch reactor. 
The wastewater sample was obtained from a pharmaceutical company in Bangi, Kuala 
Lumpur. The characteristics of the wastewater: pH 4.36; BOD5 765 mg/L; COD 
1352mg/L; TSS 71.3 mg/L; NH3-N 6.8 mg/L; N03-N 30 mg/L; total phosphorus 18.13 
mg/L; sulphate 20 mg/L, sulphide 0.28 mg/L and TKN 44.34 mg/L. The wastewater 
was treated using sequencing batch reactor process that included the following five 
stages: Fill, React, Settle, Decant and Idle. Three different HRT values were tested (12 
hr, 24 hr and 48 hr) with each cycle operating under high MLSS and low MLSS 
concentrations simultaneously. Both reactors operated with an organic loading rate of 
1.35 kg COD/m3. A 24 hr HRT showed the best performance. Optimum operating 
conditions resulted in the following effluent characteristics, COD 217±23.2 mg/L, BOD 
46±9.8 mg/L, pH 7.7±0.2, TNK 23.35±17 mg/L, N03-N 0.21±0.08 mg/L and NH3-N 
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1.1 Background of the Study 
Pharmaceuticals or medical substances are substances formulated with the 
intention of fulfilling a biological purpose of some sort. Pharmaceuticals present in 
receiving waters (after wastewater treatment) are a result of a number of sources 
such as pharmaceutical industries, animal and human excretion etc, as depicted in 
Fig 1.1 
Pig 1.1. Sources of Pharmaceuticals in Environment 
In the past, the presence of pharmaceuticals and chemicals in wastewater and 
environment was acknowledged but a challenge to quantify because of their low 
concentrations. As time progressed, more and more of these products are being used 
in hand with the developing world causing increasing concentrations noted in 
wastewater and environment. 
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The ability to quantify, however low levels of pharmaceuticals in 
environment are being documented, has alerted researchers of their threatening 
effects. Recent research confirms findings of low levels of pharmaceuticals in the 
environment and suggests that certain ingredients in the products could affect 
aquatic life and subsequently the ecosystem. Regardless of the level of wastewater 
treatment using conventional biological treatment, pharmaceuticals cannot 
effectively be treated due to the nature of the compounds. However, recent studies 
have shown promise in the use of Sequencing Batch Reactors (SBR). 
Sequencing Batch Reactors are activated sludge processing tanks which 
operate under non steady conditions for the treatment of wastewater. The 
wastewater is treated in batches with aeration and settlement both occurring in the 
same tank. There are two major differences between SBR and continuous activated 
sludge system which are that the former carries out functions of equalization aeration 
and sedimentation in time sequence and is flexible to treatment of a wide range of 
influent volumes, whereas the latter functions on a conventional space sequence and 
is limited to a fixed influent flowrate. There are five basic stages of a SBR system : 
fill, react, settle, draw and idle. Aeration of the mixed liquor occurs in the first two 
stages, seeding the influent. Sludge is formed and ammonia is broken down into 
nitrites and nitrates. The settling stage settles the sludge created in aeration phase 
with the continued consumption of oxygen leading up to the process of 
denitrification (Burton et al, 2004). 
1.2 Problem Statement 
The difficulty in treatment of pharmaceutical industrial wastewater is its 
characteristic high content of organic matter, toxicity, deep colour and high salt 
content. This, as a result, prevents standards from being met with conventional 
biological processes alone. This study served to investigate the effectiveness of the 
treatment of pharmaceutical wastewater using sequence batch reactor (SBR). 
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1.3 Objectives and Scope of the Study 
To subject the sample wastewater to biological treatment using sequencing 
hatch reactor at three hydraulic retention times (HRT) at a high and low 
biomass concentrations to determine optimum operating conditions that meet 
specified effluent standards. 
The scope of study for this project aims to fulfil the above mentioned 
objective, over a course of 12 months. These twelve months were divided into two 
semesters ie, FYP I and FYP 2. During semester one (June - December 2009) the 
work covered was centred mainly around literature search and planning. Literature 
search included the application of sequencing batch reactor to other industrial 
wastewater, treatment methods other than sequencing batch reactor that has been 
applied to pharmaceutical wastewater and cases of the use, in some way or the other, 
of sequencing batch reactor to a wastewater similar to wastewater from the 
pharmaceutical industry. 
This study is relevant in analyzing the effectiveness of pharmaceutical 
wastewater treatment by SBR as compared to other treatment methods applied in 
industry. Preliminary characterisation of the wastewater sample in terms of BOD, 
COD, suspended solids, pH, sulphates, sulphides, ammonia nitrogen, nitrate 
nitrogen, total phosphorus and total kejeldahl nitrogen (TKN) was carried out. 
Semester two was allocated to experimental work which was drawn from research 
documented in semester one. Experimental work was carried out using a bench (lab) 
scale setup of sequencing batch reactor to treat wastewater from a pharmaceutical 
company in Bangi, Kuala Lumpur. All laboratory work was conducted in 




2.1 Pharmaceutical Wastewater and Treatment 
The pharmaceutical industry uses both inorganic and organic raw materials in 
production. A wide variety of products are produced which fluctuates the 
characteristics of the wastewater effluent. Generally, most of the waste is toxic to 
biological life and is characterized by a low BOD/COD ratio (Badawy et al. 2009). 
The treatment of pharmaceutical wastewater has been a growing concern 
with an increase in their presence in receiving waters; however, treatment to the 
desired effluent standards is tricky with the wider variety on products being 
produced. The following presents some literature on pharmaceutical wastewater 
treatment using different process applications. 
A case study in southern Taiwan explored a pilot scale study of 
pharmaceutical wastewater treatment by the membrane bioreactor (MBR) process. 
The membrane bioreactor system is becoming increasingly important in wastewater 
treatment as it offers several advantages like high biodegradation efficiency and 
smaller footprint. (Fan et al, 2005). The influent wastewater to the MBR system 
consisted of real pharmaceutical manufacturing wastewater and septic tank effluent. 
The MBR plant, at a 10 m3/day capacity, consisted of an aeration tank and a 
membrane bioreactor to remove organic matter. The study demonstrated the field 
operation of pharmaceutical wastewater treatment by MBR. It was found that MBR 
system was capable of removing 95% COD and up to 99% BOD. Therefore, it is 
believed from the results that MBR system is a potential method of treating 
pharmaceutical wastewater with stable operation and satisfactory removal efficiency 
(Chang et al, 2008). 
A pharmaceutical and chemical company in south-east of Cairo, Egypt discharges 
both industrial (6000 m3/day) and municipal wastewater (128 m3/day) into a nearby 
evaporation pond without any treatment. A treatability study was carried out for this 
wastewater. The characteristics of the generated raw wastewater were COD 4100- 
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13023 mg/L, TSS 20-330 mg/L and oil grease 17,4-600 mg/L in addition to 
refractory and priority compounds. It was decided that a pre-treatment was 
necessary before the effluent could be discharged into public sewer. In light of this, 
the application of the Fenton oxidation process as a pre-treatment to biological 
process improved the removal of pharmaceuticals from wastewater and appeared to 
be an effective solution to meet effluent standards as dictated by legislation law 
(Badawy et al, 2009). 
Welly(2009) studied the treatment of a pharmaceutical wastewater by upflow 
anaerobic sludge blanket (UASB) and hybrid upflow anaerobic sludge blanket 
(HUASB) reactors. The highest COD and BOD5 removals were achieved by the 
HUASB reactor - COD removal 90% (effluent COD 133 mg/L) and BOD5 removal 
of 97% (effluent BOD5 51 mg/L). 
2.2 Sequencing Batch Reactor (SBR) 
Sequencing Batch Reactor (SBR) has a flow through process. The 
installation consists of at least two identically equipped tanks with a common 
influent inlet that can be switched between them. SBR process commonly follows a 
five step sequence of fill, react, settle, draw and idle described in detail below: 
-1t/`..., ýJ`vý". J. 1 ýys 
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Fig 2.1 Steps in the SBR process 
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Fill - Wastewater fills the tank mixing with biomass that settles during the 
previous cycle. 
React - Air is added to the tank to aid in biological growth and facilitate 
subsequent waste reduction. 
Settle - Mixing and aeration stop in this phase to allow solids to settle to the 
bottom of the tank. 
Decant - Clarified effluent is discharged. 
Idle - If necessary, sludge removal occurs in this stage. 
(http: //www. waldeninc. conl/SBR. htnl) 
The SBR process has been widely applied in the treatment of industrial 
wastewater with the ability to adjust to each application due to its flexible operating 
conditions. The following discusses some of the applications of the SBR system to 
treat wastewater from different industries. 
The Department of Environmental Engineering in Turkey carried out a study 
on the treatment of mixed pharmaceutical industry and domestic wastewater by 
sequencing batch reactor process. The characteristics of the wastewater was BOD5 
90-130 mg/L, COD 200-300 mg/L, SS 900 mg/L, pH 6.4-6.8, temperature 20°C, 
NH3 26 mg/L and P04-3 8.5 mg/L. The objective of this study was to determine the 
optimum operating conditions of the SBR and the advantages that it brought to an 
activated sludge treatment process. Optimum treatment was achieved under 4h 
aeration and 60 min of sedimentation time. Effluent characteristics from the SBR 
were BOD5 13-18 mg/L COD 25-37 mg/L, SS 9-21 mg/L, pH 7.3-7.6, temperature 
23°C, NH3 I mg/l, and PO. 3 3 8.1 mg/1- (lleri et al, 2003). 
The pulp and paper making industries are one of the largest industrial 
contributors to polluted wastewater. In China, this industry is one of the highest 
water consumers with serious pollution problems. A laboratory scale experiment to 
optimize biological treatment by optimizing operating conditions of the SBR process 
was conducted. These included mixed liquor suspended solids (MLSS) 
concentration, volumetric exchange rate (VER), aeration time, temperature and daily 
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operation cycle on biological treatment of pulp and paper mill effluent was studied 
using 4 litre sequencing batch reactors. The results showed that chemical oxygen 
demand (COD) removal efficiency was up to 93.1 ± 0.3% and the volumetric loading 
reached 1.9 kg BOD/m'/day under optimum operation. Treatment by activated 
sludge process encountered problems of filamentous bulking which the sequencing 
batch reactor process solved. The effluent quality met the discharge standard 
according to local authority and the sludge volume index (SVI) was improved to a 
healthy level as compared to treatment by activated sludge process. (Tsang et at, 
2007). 
In the treatment of dairy industry wastewater, the sequencing batch reactor 
was coupled with a membrane separation process which is a solid-liquid separation 
process. The combined system was named Membrane Sequencing Batch Reactor 
(MSBR). The process was optimized to run long term and the results showed BOD 
removal to be as high as 97-98% and stable. Membrane separation resulted in 
suspended solids free effluent. The main nutrient consumption was nitrogen for 
synthesis of new cells due to low influent concentrations. The removal efficiency 
reached 96% for nitrogen. Due to the limit of biological process, phosphorus 
removal was relatively low at 80% and depended on excess sludge wasting. (Bae et 
at, 2003) 
In Poland, two lab scale aerobic Sequencing Batch Reactors (SBR) were 
investigated to co-treat landfill leachate and wastewater from a milk factory. The 
reactors were operated at 24 hour time cycles. It was found that treatment efficiency 
strongly depended on operating conditions such as duration of different phases, 
hydraulic retention time (HRT) and organic loading. The removal efficiency of the 
of the SBR system decreased with an increased organic loading or decreased 1-IRT. 
The best effluent quality during co-treatment was achieved under 0.8kg BOD5/m3 d 
and HRT of 10 days (Ncczaj et al, 2008). 
In another study conducted in India, researchers investigated the treatment of 
a complex chemical wastewater in a sequencing batch reactor with an aerobic 
suspended growth configuration. A 24 h operating sequence was employed and 
studied with various organic loading rates (I kg COD/m3/day, I. 7kg COD/m3/day 
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and 3.5kg COD/m3/day). The SBR performance was monitored under the following 
parameters: pl-1, oxidation-reduction potential, sludge volume, sludge volume index, 
suspended solids and volatile suspended solids. Application of the SBR resulted in a 
better performance as compared to the conventional ASP system in treating complex 
chemical effluent. This may be due to enforced unsteady state conditions coupled 
with periodic exposure of the micro-organisms to defined process conditions which 
facilitate the required metabolic conditions for treating complex chemical effluents 




The pharmaceutical wastewater sample is obtained from a pharmaceutical 
company in Bangi, Kuala Lumpur. The sample is characterized according to the 
following parameters by methods outlined in the Standard Methods(2005) 
Table 3.1 Characteristics of pharmaceutical wastewater sample 
13OD5 765 
COD (mg/L) 1352 
TSS (mg/L TNR) 71.3 
NH3-N (mg/L) 6.8 
N03-N (mg/L) 30 
Total Phosphorus (mg/L) 18.13 
Sulphate (mg/L) 20 
Sulphide (mg/L) 0.28 
TKN(mg/L) 44.37 
pl-H 4.36 
As mentioned in preceding chapters, a Sequencing Batch Reactor will be 
used to in this experiment and the setup will operate as in Fig 3.1. A plan view of 
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The low pH of the raw wastewater was adjusted to a range feasible to 
biological treatment using sodium bicarbonate before treatment. A reference to Fig 
4.2 shows that the influent was kept at a pl-I between 6 and 7 and the effluent pH was 
between 7 and 9 which meets effluent standards. 
The lab scale setup consists of two reactors, one with a high mixed liquor 
suspended solids (MLSS) concentration and the other with a low MLSS 
concentration. The reactor volume is 1.5 litres each. A mixing plate and an air 
diffuser (aerator) is used during the reaction phase of the cycle. A feed tank is filled 
with influent (untreated) wastewater. The pH is adjusted here before it is fed into the 
reactors. Feeding and decanting is done by two peristaltic pumps adjusted pump IL 
per 15 min. Two effluent tanks are used for the resulting effluent from each reactor 
after settling. Aeration and mixing are done using an air diffuser and a mixing plate 
to facilitate reaction. The system was operated by an automatic timer for 12 hr and 










EFFLUENT TANK 2 
(LOW BIOMASS) 
Fig 3.3. Bench Scale Setup of SBR 
REACTOR 2 
(LOW BIOMASS) 
pH regulation by addition 
of bicarbonate of soda 
Acclimation was carried out over a period of 2 weeks with the following 
ratios of domestic wastewater / pharmaceutical wastewater: 75/25,50/50,25/75, 
0/100. These ratios were each carried out for 3 days each until the bacteria was 
acclimatized to the environment of the pharmaceutical wastewater. After the 
acclimation period, the Hydraulic Retention Times (HRT = 12,24 and 48 hours) 
were tested with two different mixed liquor suspended solids (MLSS) concentrations 
(low MLSS and high MLSS) (Table 3.1). During a cycle, the reactors had the 













Fig 3.4 Reactor volumes for each stage in SBR cycle 
After Acclimation stage the SBR's were fed at following organic loading rates : 
Table 3.3 Organic Loading Rates 
HRT Organic Loading Rate 
12 hr 2.702 kg/m /day 
24 hr 1.352 kg/m /day 
48 hr 0.676 kg/m /day 
During the experimental work, chemical oxygen demand (COD), ammonia 
nitrogen (NI-13-N) and nitrate nitrogen (N03-N) was tested on a daily basis. 
Biochemical oxygen demand (BOD), total kjeldahl nitrogen (TKN), mixed liquor 
suspended solids (MLSS) and mixed liquor volatile suspended solids (MLVSS) was 
measured on a weekly basis. The flow of this project from January 2009 - May 
2010 was carried out as illustrated in Figure 3.5. 
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The influent wastewater was initially relatively white however turned dark 
grey over time. The color change was evident after a change in pH. This is assumed 
to be due to the large amount of unknown componds present in the sample that may 
be undergoing reaction. The colour change affected the effluent colour and thus the 
standard procedure for determining nitrates in the effluent was affected. An alternate 
approach was taken using Ion Chromatography which will be implemented for the 
rest of the study. 
During the study it was found that the reactor with a low biomass 
concentration developed a frothing problem. This is a result of the detergents and 
other surfactants in the wastewater. Sludge from the high biomass reactor was 
recylced into the low biomass reactor so to minimze frothing. An antifoaming 
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Fig 3.5 Flowchart of FYP tasks 
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CHAPTER 4 
RESULTS AND DISCUSSION 
4.1. Effect of Cycle Period 
4.1.1 HRT of 12 hr 
Table 4.1.1: Concentrations for HRT = 12 hr 
COD m /L BOD m /L 
Low MLSS 269±14 119±8 
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Fig 4.1.1 a. Effluent COD for HRT of 12 hr under low MLSS 
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Fig 4.1. I b. Effluent COD for HRT of 12 hr under high MLSS 
COD concentrations for the 12 hr cycle are more than twice as expected by 
effluent standards. Although removal efficiency is approximately 80 % this still 
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Fig 4.1.1d. Effluent BOD for HRT of 12 hr under high MLSS 
Expected effluent BOD concentrations are not met with a 12 hour HR"I'. 
There is a significant reduction in BOD by more than 80 % however because of the 
high BOD in the influent wastewater a 12 hour HRT was not sufficient for effective 
removal. 
Nutrient removal at the 12 hour HRT shows a 45-55% removal for total 
Kjeldhal nitrogen with the effluent wastewater having an average TKN 
concentration of approximately 23 mg/L. Effluent ammonia had removal of 80 % at 
an average concentration of 1.4 mg/L as compared to the influent concentration of 
6.8 mg/L. 
The effluent pH was with the range of 7.7 - 8.2 which is within required 
standards with the infulent ranging between 5.9 - 6.5 after pH adjustment using 
sodium bicarbonate. 
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4.1.2 H RT of 24 hr 
Table 4.1.2 : Concentrations for HRT = 24 hr 
COD BOD 
Low MLSS 217±23.2 46±9.8 
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Fig 4.1.2b. Effluent COD for 1-IRT of 24 hr under high MLSS 
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The 24 hour HRT shows a better COD removal as compared to the 12 hour 
HRT. The COD concentration for the 24 hour HRT averages at 217 mg/L as 
compared to the 269 mg/L present in the effluent after a 12 hour HR"1'. This is 
clearly due to an increase in reaction time. COD removal at 24 hr HRT is at an 
average of 84 %. This is still however, lower than that obtained from other 
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Fig 4.1.2d. Effluent BOD for HRT of 24 hr under high MLSS 
BOD removal improved more than COD during the 24 hour HRT. The 24 
hour treatment just meets the standard for effluent BOD of 50 mg/L for standard B. 
BOD removal is now 94 % which is lower but a competitive efficiency to treatment 
by MBR, IIUASB, Fenton-Biological (Chang et at, 2008; Welly, 2009; Bedawy et 
al, 2009) 
Nutrient Removal for the 24 hour HRT is not as effective as ammonia % 
removal lies between 35-44 %. The initial ammonia concentration was 6.8 mg/L. 
Effluent had a total Kjeldhal nitrogen removal was 49-59% at an average 
concentration of 23 mg/L. 
Effluent pH was maintained at 7.3-8.1 with the influent ranging 5.5-7.0 after 
pH adjustment using sodium bicarbonate. 
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4.1.3 HRT of 48 hr 
Table 4.1.3: Removal Efficiency(%) for HRT = 48 hr 
COD BOD 
Low MLSS 217+22 50±7.2 
High MLSS 219±9.0 54±5.4 
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Fig 4.1.3b. Effluent COD for HRT of 48 hr under high MLSS 
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Treatment at 48 hour I IRT and at 24 hour HRT show similar outcomes. A 48 
hour HRT of course would have a higher operating cost with the same output which 
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Fig 4.1.3d. Effluent BOD for HRT of 48 hr under high MLSS 
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As noted for COD removal, the 48 hour HRT results in a similar BOD 
removal as a 24 hour HRT. 
The 48 hour HRT nutrient removal rates were not as stable as those at 12 and 
24 hour HRT. Due to logistics matters with the use of the premises during the 
weekends, the setup was left to run over the weekend and then reset at the beginning 
of the week. This could have affected the nutrient values however it was noted that 
TKN was removed at 41 % for the reactor operating at high MLSS. Ammonia 
concentrations in the effluent was also high as expected due to high TKN values. 
Effluent pH was within the range of 7.4-7.9 with the influent ranging from 
6.2-6.6 after pH adjustment by sodium bi carbonate. 
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4.2. Effect of MLSS Concentration 
The mixed liquor suspended solids (MLSS) concentration as well as the mixed 
liquor volatile suspended solids (MLVSS) in both reactors were monitored and are 
presented in the graph below. 
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Fig 4.2.2. Effect of MLSS concentration on COD removal for different HRT 
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Fig 4.2.3. Effect of MLSS on BOD removal for different HRT 
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It is evident that the MLSS concentration does not have a significant effect 
on the performance of the sequencing batch reactor. Low MLSS and High MLSS 
concentrations result in similar percentage removals for COD and BOD. 
At 12 hour HRT the performance is significantly lower than at 24 and 48 
hour HRT. However there is no difference in performance between the 24 hour and 
48 hour HRT. Both have a sufficient removal of BOD to meet the effluent 
standards. COD for the 24 and 48 hour HRT however is still much higher than 
allowed by the effluent standards. 
Therefore, it will be more feasible to make favour the 24 hour HRT operating 
parameters over the 48 hour HRT as operation costs will be much less with the same 
output. 
A pre-treatment may make it possible for this system to accomplish effluent 
standards by reducing influent concentrations to the sequencing batch reactor. 
27 
CHAPTER 5 
CONCLUSION AND RECOMMENDATION 
The purpose of this study was to determine the optimum operating conditions 
of a sequencing batch reactor for treatment of the pharmaceutical wastewater. This 
was done by analysing the effect different cycle periods and different biomass 
concentrations on the treatment efficiency. 
The 24 and 48 hr hydraulic retention time showed similar results. Both these 
HRTs have a significantly higher treatment efficiency than the 12 hr HRT. 
However, 24 hr HRT is favored over the 48 hr HRT so as to save on operation costs. 
The increase in MLSS did not affect the SBR performance and therefore, the 
optimum operating conditions of a sequencing batch reactor for treatment of the 
pharmaceutical wastewater is at a 24 hr hydraulic retention time with cycle period of 
15 min idle, 15 min feed, 9.25 hr react, 2 hr settle and 15 min decant. 
Under these optimum operating conditions, the final effluent characteristics 
were COD 217±23.2 mg/L, BOD 46±9.8 mg/L, pH 7.7±0.2, TKN 23.35±17 mg/L, 
N03-N 0.21±0.08 mg/L and NH3-N 4.4±2.1 mg/L. 
Since effluent standards are still not met with these operating conditions it is 




'Table 6.1 : Cost of Laboratorv Eauinment 
ITEM QUANTITY COST 
Reactor vessel (2L Plastic 
container) 
2 Lab equip 
Mixing Plate 2 Lab equip 
Peristaltic Pump 2 Lab equip 
Feed Vessel I Lab equip 
Effluent Vessel 2 Lab equip 
Plastic tubing 2m Lab equip 
Sodium Bicarbonate 1x50g RM2 
Aerator (aquarium pump) I RM7 
Automatic Timer 3 RM30 
Total Cost RM39 
The setup was run over 15 weeks. These costs exclude electricity usage. 
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C 140 40 
pH Value - 
6.0-9.0 5.5-9.0 
BOD5 at 20C mg/I 20 50 
COD mg/I 50 100 
Suspended Solids mg/I 50 100 
Mercury mg/I 0.005 0.05 
Cadmium mg/I 0.01 0.02 
Chromium, Hexavalent mg/I 0.05 0.05 
Arsenic mg/I 0.05 0.10 
Cyanide mg/I 0.05 0.10 
Lead mg/I 0.10 0.5 
Chromium, Trivalent mg/I 0.20 1.0 
Copper mg/I 0.20 1.0 
Manganese mg/I 0.20 1.0 
Nickel mg/I 0.20 1.0 
Tin mg/I 0.20 1.0 
Zinc mg/I 1.0 1.0 
Boron mg/I 1.0 4.0 
Iron (Fe) mg/I 1.0 5.0 
Phenol mg/I 0.001 1.0 
Free Chlorine mg/I 1.0 2.0 
Sulphide mg/I 0.50 0.5 
Oil and Grease Img/I Not Detectable 10.0 
Environmental Quality (Sewage and Industrial Effluent) Regulations 1979. 





I Table B1 : Summary of results for HRT 12 hours 

































1 257 246 122 116 1.3 1.3 0 0.048 7.9 7.8 1 72.39 35.03 4187 5840 2427 4200 
2 292 279 135 131 1.2 1.4 0 0 7.9 8.0 2 18.68 18.68 4307 6267 2987 4600 
3 247 228 129 120 1.5 1.1 0.039 0 7.6 7.6 3 18.68 18.21 4107 6200 2920 4360 
4 276 226 111 102 1.3 1.2 0 0 8.1 8.0 
5 271 248 121 115 1.3 1.4 0 0 7.7 7.6 
6 254 245 116 107 1.2 1 0 0.01 7.7 7.6 
7 281 264 110 105 1.3 1.5 0 0 8.0 7.7 1 
8 285 268 117 106 1.4 1 0 0 7.9 7.8 
9 277 272 123 110 1.4 1.2 0.022 0 7.3 7.4 
10 264 259 118 106 1.4 1.5 0 0 7.4 7.6 
11 261 257 111 108 1.6 1.9 0 0 7.6 7.5 
Table B2 : Summary of results for HRT 24 hours 
























MLSS LOW HIGH LOW HIGH 
1 243 261 62 70 1.3 2.6 7.9 7.8 1 77.76 50.20 3907 7480 2427 3907 
2 250 245 48 49 1.7 2.3 7.9 8.0 2 49.04 35.03 4520 5653 2520 4507 
3 224 235 28 31 2.3 2.7 7.6 7.6 3 11.68 7.47 3960 5320 2707 3587 
4 264 215 28 31 3.8 4.2 8.1 8.0 4 35.03 11.68 3653 5747 2460 3340 
5 192 205 48 56 4.4 2.9 7.7 7.6 
6 216 209 54 56 6 5.5 7.7 7.6 
7 213 210 52 56 7.7 6.7 8.0 7.7 
8 215 211 43 46 7.1 6.8 7.9 7.8 
9 197 215 42 45 5.8 5.8 0.344 0.587 7.3 7.4 
10 198 211 40 42 1.8 1.6 0.122 0.294 7.4 7.6 
11 186 210 46 45 4.6 2.9 0.205 0.516 7.6 7.5 
12 218 237 54 56 5.1 3.2 0.196 0.333 7.6 7.6 
13 209 221 49 39 5.2 3.2 0.179 0.361 7.6 7.7 
Table B3 : Summa ný of results for HRT 48 hours 




























MLSS LOW HIGH 
1 202 209 42 51 11.9 10.1 0.78 1.52 7.8 7.9 1 101.11 77.76 3973 6027 2773 3427 
3 179 217 43 52 9 11 1.77 4.72 7.6 7.7 2 96.44 49.74 3720 5813 2413 3587 
5 233 230 60 63 1.8 2 1.8 4.35 7.6 7.7 3 96.44 31.06 3827 5893 2627 3920 
7 225 209 48 48 1.6 1.6 1.67 3.26 7.5 7.4 
9 231 224 56 58 2.3 1.6 1.9 4.8 7.6 7.7 
11 231 226 53 54 1.4 1.2 2.77 5.75 7.5 7.6 
